We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBI
926
Trueblue
TBI
$276M
$1.12M ﹤0.01%
50,300
VIPS icon
927
Vipshop
VIPS
$5.75B
$1.12M ﹤0.01%
204,310
+365
+0.2% +$1.96K
ENOR icon
928
iShares MSCI Norway ETF
ENOR
$179M
$1.11M ﹤0.01%
48,300
AKAO
929
DELISTED
Achaogen Inc
AKAO
$1.11M ﹤0.01%
903,425
XLE icon
930
State Street Energy Select Sector SPDR ETF
XLE
$43.3B
$1.11M ﹤0.01%
38,660
+340
+0.9% +$11.4K
LCTX icon
931
Lineage Cell Therapeutics
LCTX
$268M
$1.11M ﹤0.01%
1,212,600
-1,189,957
-50% -$1.82M
CNXN icon
932
PC Connection
CNXN
$2.15B
$1.1M ﹤0.01%
37,136
-4,400
-11% -$141K
NXST icon
933
Nexstar Media Group
NXST
$5.2B
$1.1M ﹤0.01%
14,000
-125,000
-90% -$9.89M
ON icon
934
ON Semiconductor
ON
$28.5B
$1.07M ﹤0.01%
64,688
-455,000
-88% -$7.87M
CAH icon
935
Cardinal Health
CAH
$54.1B
$1.06M ﹤0.01%
23,734
-8,100
-25% -$422K
DOC icon
936
Healthpeak Properties
DOC
$13.9B
$1.06M ﹤0.01%
37,813
FBC
937
DELISTED
Flagstar Bancorp, Inc. New
FBC
$1.05M ﹤0.01%
39,900
-119,600
-75% -$3.57M
QSR icon
938
Restaurant Brands International
QSR
$26.3B
$1.05M ﹤0.01%
20,115
-30,700
-60% -$1.7M
RMBS icon
939
Rambus
RMBS
$9.01B
$1.05M ﹤0.01%
137,200
-24,000
-15% -$209K
ADI icon
940
Analog Devices
ADI
$175B
$1.05M ﹤0.01%
12,245
-2,000
-14% -$173K
PBP icon
941
Invesco S&P 500 BuyWrite ETF
PBP
$381M
$1.05M ﹤0.01%
52,970
+5,450
+11% +$116K
WK icon
942
Workiva
WK
$4.07B
$1.03M ﹤0.01%
+28,800
New +$1.01M
IQV icon
943
IQVIA
IQV
$44.4B
$1.03M ﹤0.01%
8,880
+830
+10% +$101K
ACC
944
DELISTED
American Campus Communities, Inc.
ACC
$1.03M ﹤0.01%
+24,824
New +$1.03M
KB icon
945
KB Financial Group
KB
$45.5B
$1.02M ﹤0.01%
24,421
VSH icon
946
Vishay Intertechnology
VSH
$4.82B
$1.02M ﹤0.01%
56,860
-96,532
-63% -$1.82M
VNQI icon
947
Vanguard Global ex-US Real Estate ETF
VNQI
$3.36B
$1.02M ﹤0.01%
19,420
+1,300
+7% +$70.1K
OSB
948
DELISTED
Norbord Inc.
OSB
$1.02M ﹤0.01%
38,200
+17,800
+87% +$485K
TRIP icon
949
TripAdvisor
TRIP
$1.06B
$1M ﹤0.01%
18,603
-133,300
-88% -$7.38M
USRT icon
950
iShares Core US REIT ETF
USRT
$4.38B
$1M ﹤0.01%
22,300
-1,750
-7% -$82.9K

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.